Prof Maria Ribal discusses how effective dissemination is key to PIONEER’s long-term success
Prof Maria Ribal discusses how effective dissemination is key to PIONEER’s long-term success
Dr Mieke Van Hemelrijck explains the importance of define core outcome sets for prostate cancer
PIONEER research associates from both academic and industry discuss their experience of working together
Dr Thomas Abbott, EFPIA co-lead for PIONEER, discusses data sources and access to data
Dr Zsuzsanna Devecseri, EFPIA co-lead for PIONEER, discusses prostate cancer outcomes
Cardiac events following radical radiotherapy for lung cancer
Future directions in glioblastoma: the potential role of TKIs
Pre-operative radiation for pancreatic cancer
Second-line and beyond in mCRC: Optimising the benefit and reducing the risk
Controversies in the management of prostate cancer
Local treatment in oligometastatic prostate cancer: Radiotherapy
SBRT photons, protons or carbon for prostate cancer: How good is the data?